Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Dranoff

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Cancer Research|June 24, 2000
Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligandN Mach, S Gillessen, S B Wilson, et al.
The Journal of Clinical Investigation|February 1, 1996
Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient miceJ A Huffman, W M Hull, G Dranoff, et al.
Cancer Research|September 1, 1985
Influence of glutamine on the growth of human glioma and medulloblastoma in cultureG Dranoff, G B Elion, H S Friedman, et al.
The American Journal of Physiology|September 1, 1996
A gene transfer system establishes interleukin-6 neither promotes nor suppresses renal injuryT Naito, H Yokoyama, K J Moore, et al.
Molecular Medicine (Cambridge, Mass.)|May 1, 1996
Macrophage growth factors introduced into the kidney initiate renal injuryT Naito, H Yokoyama, K J Moore, et al.
Blood|February 27, 2001
Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABLS Li, S Gillessen, M H Tomasson, et al.
Cancer Research|February 24, 2001
Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantationT Teshima, N Mach, G R Hill, et al.
The American Journal of Physiology|April 1, 1996
Surfactant metabolism in transgenic mice after granulocyte macrophage-colony stimulating factor ablationM Ikegami, T Ueda, W Hull, et al.
Blood|February 7, 1998
Gene immunotherapy in murine acute myeloid leukemia: granulocyte-macrophage colony-stimulating factor tumor cell vaccines elicit more potent antitumor immunity compared with B7 family and other cytokine vaccinesK Dunussi-Joannopoulos, G Dranoff, H J Weinstein, et al.
The American Journal of Physiology|November 14, 1997
GM-CSF enhances lung growth and causes alveolar type II epithelial cell hyperplasia in transgenic miceJ A Huffman Reed, W R Rice, Z K Zsengellér, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Cancer Research|June 24, 2000
Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligandN Mach, S Gillessen, S B Wilson, et al.
The Journal of Clinical Investigation|February 1, 1996
Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient miceJ A Huffman, W M Hull, G Dranoff, et al.
Cancer Research|September 1, 1985
Influence of glutamine on the growth of human glioma and medulloblastoma in cultureG Dranoff, G B Elion, H S Friedman, et al.
The American Journal of Physiology|September 1, 1996
A gene transfer system establishes interleukin-6 neither promotes nor suppresses renal injuryT Naito, H Yokoyama, K J Moore, et al.
Molecular Medicine (Cambridge, Mass.)|May 1, 1996
Macrophage growth factors introduced into the kidney initiate renal injuryT Naito, H Yokoyama, K J Moore, et al.
Blood|February 27, 2001
Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABLS Li, S Gillessen, M H Tomasson, et al.
Cancer Research|February 24, 2001
Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantationT Teshima, N Mach, G R Hill, et al.
The American Journal of Physiology|April 1, 1996
Surfactant metabolism in transgenic mice after granulocyte macrophage-colony stimulating factor ablationM Ikegami, T Ueda, W Hull, et al.
Blood|February 7, 1998
Gene immunotherapy in murine acute myeloid leukemia: granulocyte-macrophage colony-stimulating factor tumor cell vaccines elicit more potent antitumor immunity compared with B7 family and other cytokine vaccinesK Dunussi-Joannopoulos, G Dranoff, H J Weinstein, et al.
The American Journal of Physiology|November 14, 1997
GM-CSF enhances lung growth and causes alveolar type II epithelial cell hyperplasia in transgenic miceJ A Huffman Reed, W R Rice, Z K Zsengellér, et al.
Pageof 6